| Literature DB >> 25166273 |
Prema Sriram1, Chenyu Wang2, Con Yiannikas3, Raymond Garrick4, Michael Barnett2, John Parratt5, Stuart L Graham6, Hemamalini Arvind6, Alexander Klistorner6.
Abstract
PURPOSE: Loss of retinal ganglion cells in in non-optic neuritis eyes of Multiple Sclerosis patients (MS-NON) has recently been demonstrated. However, the pathological basis of this loss at present is not clear. Therefore, the aim of the current study was to investigate associations of clinical (high and low contrast visual acuity) and electrophysiological (electroretinogram and multifocal Visual Evoked Potentials) measures of the visual pathway with neuronal and axonal loss of RGC in order to better understand the nature of this loss.Entities:
Mesh:
Year: 2014 PMID: 25166273 PMCID: PMC4148263 DOI: 10.1371/journal.pone.0102546
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 3Figure 3a: Correlation of mfVEP latency with temporal RNFL thickness. Figure 3b: Correlation of mfVEP latency with total RNFL thickness. Figure 3c: Correlation of mfVEP latency with GCL thickness.
Figure 4Figure 4a: Correlation of mfVEP amplitude with temporal RNFL thickness. Figure 4b: Correlation of mfVEP amplitude with total RNFL thickness. Figure 4c: Correlation of mfVEP amplitude with GCL thickness.
Figure 5Figure 5a: Correlation of photopic ERG b-wave latency with temporal RNFL thickness. Figure 5b: Correlation of photopic ERG b-wave latency with total RNFL thickness. Figure 5c: Correlation of photopic ERG b-wave latency with GCL thickness.
Figure 1OCT scanning pattern (left) and segmentation of retinal layers (right).
Comparison of functional and structural measurements in controls and MS-NON eyes.
| Control (n = 25) | MS-NON eyes (n = 58) | MS-NON eyes (n = 58) | |
| Mean±SD | Mean±SD | p value | |
| Global RNFL (µ) | 99.2±7.5 | 93.6±9.9 | 0.002 |
| Temp RNFL (µ) | 70.8±7.8 | 64.2±9.3 | 0.0002 |
| GCL (µ) | 86.5±5.5 | 81.4±7.1 | <0.0001 |
| mfVEP amplitude (µV) | 238.1±36.1 | 151.6±42.9 | <0.0001 |
| mfVEP latency (µV) | 149.3±5.1 | 161.5±9.2 | <0.0001 |
| Dim white b-wave amplitude (µV) | 354.4±134.8 | 353.7±90.7 | 0.92 |
| Dim white b-wave latency (ms) | 97.7±8.9 | 97.3±7.9 | 0.89 |
| Dark max 3 a-wave amplitude (µV) | −268.3±48.4 | −287.0±58.8 | 0.11 |
| Dark max 3 a-wave latency (ms) | 16.6±1.4 | 16.8±0.6 | 0.37 |
| Dark max 3 b-wave amplitude (µV) | 490.9±103.8 | 524.5±104.6 | 0.10 |
| Dark max 3 b-wave latency (ms) | 53.1±3.6 | 53.9±4.0 | 0.26 |
| Dark max 12 a-wave amplitude (µV) | −325.5±52.4 | −342.5±64.6 | 0.20 |
| Dark max 12 a-wave latency (ms) | 13.5±1.1 | 13.7±0.9 | 0.43 |
| Dark max 12 b-wave amplitude (µV) | 511.9±109.2 | 537.0±111.1 | 0.27 |
| Dark max 12 b-wave latency (ms) | 52.9±1.9 | 53.4±1.5 | 0.17 |
| Photopic a-wave amplitude (µV) | −41.4±18.1 | −46.3±10.9 | 0.15 |
| Photopic a-wave latency (ms) | 15.1±0.8 | 15.4±0.6 | 0.06 |
| Photopic b-wave amplitude (µV) | 174.7±35.5 | 185.3±41.4 | 0.21 |
| Photopic b-wave latency (ms) | 29.8±0.8 | 30.4±0.8 | 0.004 |
*p value calculated using student t-test.
Figure 2Figure 2a: Correlation of temporal RNFL thickness between the right and left eyes in MS patients without ON in either eye. Figure 2b: Correlation of mfVEP latency between the right and left eyes in MS patients without ON in either eye.
Correlation with LCVA.
| LCVA 2.5% contrast | LCVA 2.5% contrast | LCVA 1.25% contrast | LCVA 1.25% contrast | |
| Correlation (r) | p value | Correlation (r) | p value | |
| Global RNFL | 0.44 | 0.003 | 0.4 | 0.008 |
| Temporal RNFL | 0.39 | 0.01 | 0.32 | 0.03 |
| mfVEP amplitude | 0.47 | 0.002 | 0.36 | 0.02 |
| mfVEP latency | −0.39 | 0.01 | −0.41 | 0.007 |
Linear Regression Model.
| GCL | GCL | Global RNFL | Global RNFL | Temporal RNFL | Temporal RNFL | |
| Variables | Stand Beta | Sig | Stand Beta | Sig | Stand Beta | Sig |
| mfVEP latency | −0.46 | <0.001 | −0.61 | <0.001 | −0.56 | <0.001 |
| Photopic b-wave ERG latency | −0.25 | 0.04 | −0.24 | 0.03 |